Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The vigilance decrement: its first 75 years.

Frontiers in cognition·2026
Same author

Does the output form of inhibition of return operate at or after the bottleneck?

Acta psychologica·2025
Same author

Role of social competence in emotion processing among emerging adults with anxiety.

Scientific reports·2025
Same author

Attention to Instagram features in female youth with anxiety symptoms.

Comprehensive psychiatry·2025
Same author

Posner's Endogenous Beam Is (Still) Not Treisman's Glue.

Experimental psychology·2025
Same author

Neurochemical and Circuit Heterogeneity of Cognition-Modulating Prefrontal Corticotropin-Releasing Factor Neurons.

Biological psychiatry·2025

Related Experiment Video

Updated: May 26, 2026

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
10:02

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

Published on: March 12, 2020

Psychostimulants act within the prefrontal cortex to improve cognitive function.

Robert C Spencer1, Raymond M Klein, Craig W Berridge

  • 1Department of Psychology, University of Wisconsin Madison, Madison, Wisconsin, USA.

Biological Psychiatry
|January 3, 2012
PubMed
Summary
This summary is machine-generated.

Methylphenidate (MPH) enhances cognitive function by acting within the prefrontal cortex (PFC). This study shows direct evidence that the PFC is a key site for MPH

More Related Videos

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
13:20

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance

Published on: December 5, 2025

High-definition Transcranial Direct Current Stimulation over Right Dorsolateral Prefrontal Cortex to Enhance Metacognitive Sensitivity
06:11

High-definition Transcranial Direct Current Stimulation over Right Dorsolateral Prefrontal Cortex to Enhance Metacognitive Sensitivity

Published on: September 26, 2025

Related Experiment Videos

Last Updated: May 26, 2026

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
10:02

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

Published on: March 12, 2020

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
13:20

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance

Published on: December 5, 2025

High-definition Transcranial Direct Current Stimulation over Right Dorsolateral Prefrontal Cortex to Enhance Metacognitive Sensitivity
06:11

High-definition Transcranial Direct Current Stimulation over Right Dorsolateral Prefrontal Cortex to Enhance Metacognitive Sensitivity

Published on: September 26, 2025

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cognitive Science

Background:

  • Psychostimulants, like methylphenidate (MPH), improve cognitive and behavioral functions linked to the prefrontal cortex (PFC) and frontostriatal circuits.
  • These effects are observed in individuals with ADHD and healthy subjects, but the precise brain regions responsible remain unclear.
  • Research suggests MPH's cognition-enhancing effects may stem from direct action within the PFC or frontostriatal circuitry.

Purpose of the Study:

  • To investigate the specific frontostriatal subfields where methylphenidate (MPH) exerts its cognition-enhancing effects.
  • To determine if MPH acts directly within the PFC to improve PFC-dependent cognitive tasks.
  • To assess MPH's impact on spatial working memory performance via microinfusion into distinct brain regions.

Main Methods:

  • Rats received microinfusions of varying doses of MPH or vehicle into the dorsomedial PFC, ventromedial PFC, or dorsomedial striatum.
  • Working memory was evaluated using a delayed-response test assessing PFC-dependent cognition.
  • Performance was compared between different infusion sites and doses.

Main Results:

  • Microinfusion of MPH into the dorsomedial PFC, but not the ventromedial PFC, resulted in an inverted U-shaped improvement in cognitive performance.
  • The magnitude of cognitive enhancement from direct PFC infusion matched that observed with systemic MPH administration.
  • Infusion of MPH into the dorsomedial striatum did not impact working memory, despite the region's necessity for task performance.

Conclusions:

  • The prefrontal cortex (PFC) is definitively identified as a primary site of action for the cognition-enhancing effects of low-dose methylphenidate (MPH).
  • These findings support the PFC as a crucial target for the therapeutic actions of psychostimulants.
  • This study provides direct evidence for the role of the PFC in mediating MPH's cognitive benefits.